tiprankstipranks
Advertisement
Advertisement
Nexalin Advances Pivotal HALO Clarity Trial for Insomnia
PremiumCompany AnnouncementsNexalin Advances Pivotal HALO Clarity Trial for Insomnia
3M ago
Nexalin announces continued advancement toward trial evaluating HALO Clarity
Premium
The Fly
Nexalin announces continued advancement toward trial evaluating HALO Clarity
3M ago
Nexalin announces continued advancement toward trial evaluating HALO Clarity
Premium
The Fly
Nexalin announces continued advancement toward trial evaluating HALO Clarity
3M ago
Nexalin Technology announces publication of peer-reviewed study on DIFS
PremiumThe FlyNexalin Technology announces publication of peer-reviewed study on DIFS
5M ago
Nexalin Technology Unveils New Investor Presentation on DIFS
Premium
Company Announcements
Nexalin Technology Unveils New Investor Presentation on DIFS
6M ago
Nexalin Technology completes FDA Q-sub meeting for Gen-2 SYNC neurostimulation
Premium
The Fly
Nexalin Technology completes FDA Q-sub meeting for Gen-2 SYNC neurostimulation
6M ago
Nexalin Technology announces regulatory approval to sell Gen 2 SYNC
PremiumThe FlyNexalin Technology announces regulatory approval to sell Gen 2 SYNC
7M ago
Nexalin announces three studies published on Gen-2 Nexalin DIFS technology
Premium
The Fly
Nexalin announces three studies published on Gen-2 Nexalin DIFS technology
7M ago
Nexalin Technology Amends Equity Distribution Agreement
Premium
Company Announcements
Nexalin Technology Amends Equity Distribution Agreement
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100